| Product Code: ETC9961046 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Blood Transfusion Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Blood Transfusion Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Blood Transfusion Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Blood Transfusion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for blood transfusions in the United States due to a growing aging population and rising prevalence of chronic diseases. |
4.2.2 Technological advancements in blood transfusion diagnostics leading to more accurate and efficient testing procedures. |
4.2.3 Rising awareness about the importance of blood safety and the need for reliable transfusion diagnostics. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and standards for blood transfusion diagnostics products, leading to higher compliance costs for manufacturers. |
4.3.2 Limited availability of skilled professionals to perform complex blood transfusion diagnostic tests. |
4.3.3 High costs associated with blood transfusion diagnostics equipment and tests, impacting adoption rates. |
5 United States (US) Blood Transfusion Diagnostics Market Trends |
6 United States (US) Blood Transfusion Diagnostics Market, By Types |
6.1 United States (US) Blood Transfusion Diagnostics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, By Kits and Reagents, 2021- 2031F |
6.2 United States (US) Blood Transfusion Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, By Blood Grouping, 2021- 2031F |
6.2.3 United States (US) Blood Transfusion Diagnostics Market Revenues & Volume, By Disease Screening, 2021- 2031F |
7 United States (US) Blood Transfusion Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Blood Transfusion Diagnostics Market Export to Major Countries |
7.2 United States (US) Blood Transfusion Diagnostics Market Imports from Major Countries |
8 United States (US) Blood Transfusion Diagnostics Market Key Performance Indicators |
8.1 Rate of adoption of new blood transfusion diagnostic technologies in the United States. |
8.2 Number of accredited blood transfusion diagnostic laboratories in the country. |
8.3 Percentage of successful and accurate blood transfusion diagnostic tests conducted. |
8.4 Average turnaround time for blood transfusion diagnostic test results. |
8.5 Rate of complications or errors in blood transfusion diagnostics processes. |
9 United States (US) Blood Transfusion Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Blood Transfusion Diagnostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Blood Transfusion Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Blood Transfusion Diagnostics Market - Competitive Landscape |
10.1 United States (US) Blood Transfusion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Blood Transfusion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here